(Erstwhile UTI Pharma & Healthcare Fund) Table of Contents The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis UTI Healthcare Fund - G
Scheme Objective
CAGR
return of 15.4% since its launch. Ranked 40 in Sectoral
category. Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% . NAV as on 4 Nov 24 ₹284.107 ↓ -1.03 (-0.36 %) Net Assets (AUM) as on 30 Sep 2024 ₹1,201 Cr. Launch Date 28 Jun 1999 Category Equity - Sectoral Rating ☆ Type Open Ended Fund Risk High AMC UTI Asset Management Company Ltd Alpha Ratio 1.27 Expense Ratio 2.38 % Sharpe Ratio 2.507 Information Ratio -0.21 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-1 Years (1%),1 Years and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 4 Nov 24 Duration Returns 1 Month -1% 3 Month 7.8% 6 Month 26% 1 Year 56.4% 3 Year 20.1% 5 Year 28.1% 10 Year 15 Year Since launch 15.4% Historical Annual Returns
Year Returns 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Growth of 10k Over Years
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹15,449 31 Oct 21 ₹19,772 31 Oct 22 ₹18,618 31 Oct 23 ₹21,719 31 Oct 24 ₹34,592 Asset Allocation
Asset Class Value Cash 3.26% Equity 96.63% Debt 0.11% Sector Allocation
Sector Value Health Care 94.08% Basic Materials 1.3% Financial Services 1.24% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMADrug Manufacturers - Specialty & Generic 12% ₹142 Cr 735,274 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087Drug Manufacturers - General 6% ₹74 Cr 450,000
↓ -19,180 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331Drug Manufacturers - Specialty & Generic 5% ₹64 Cr 200,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDYDrug Manufacturers - Specialty & Generic 5% ₹59 Cr 87,100 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSPMedical Care Facilities 4% ₹47 Cr 64,796 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 532296Drug Manufacturers - Specialty & Generic 3% ₹42 Cr 250,331 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHLDrug Manufacturers - Specialty & Generic 3% ₹40 Cr 74,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843Medical Care Facilities 3% ₹39 Cr 634,445 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERISDrug Manufacturers - Specialty & Generic 3% ₹37 Cr 275,361
↓ -22,385 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMADrug Manufacturers - Specialty & Generic 3% ₹37 Cr 250,000
Talk to our investment specialistFund Managers
Name Since Tenure Kamal Gada 2 May 22 2.42 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point Citibank N.A. India Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East), Stock Holding Corporation of India Mittal Court, ‘B’ Wing,,Nariman Point Registrar & Transfer Agent
KFin Technologies Ltd Address 138 -Suyesh Solitaire, Nr. Podar International School,Kudasan, Gandhinagar, Gujarat FAX N.A Email N.A Administrator Companies
Company Address UTI Mutual Fund UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E) Auditors
Company Address Haribhakti & Co. Chartered Accountants 42, Free Press House,4th Floor,,215, Nariman Point, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year UTI Healthcare Fund
Growth ₹284.107
↓ -1.03 26.05 % 56.39 % 20.12 % 28.08 % UTI Healthcare Fund
Normal Dividend, Payout ₹219.575
↓ -0.80 26.05 % 56.39 % 20.12 % 28.08 % UTI Healthcare Fund
Normal Dividend, Reinvestment ₹219.575
↓ -0.80 26.05 % 56.39 % 20.12 % 28.08 % Data as on 4 Nov 24